 | • レポートコード：QYR2104Z5473 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、皮下注射のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（皮下注射器具、皮下注射治療薬、その他）、用途別市場規模（病院、診療所、検査室、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・皮下注射の市場動向 ・企業の競争状況、市場シェア ・皮下注射の種類別市場規模（皮下注射器具、皮下注射治療薬、その他） ・皮下注射の用途別市場規模（病院、診療所、検査室、その他） ・皮下注射の北米市場規模2016-2027（アメリカ、カナダ） ・皮下注射のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・皮下注射のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・皮下注射の中南米市場規模2016-2027（メキシコ、ブラジル） ・皮下注射の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Becton Dickinson、Daiichi Sankyo、Sanofi、Roche、GSK、Eli Lilly、Asahi Kasei Pharma、Takeda Pharmaceutical、Antares Pharma, Inc.、Eisai Co.，Ltd、Chugai Pharmaceutical、Endo International、PenJet Corporation、Aspen Medical Group） ・結論 |
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as “skin popping”. Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.
Market Analysis and Insights: Global Subcutaneous Injection Market
The global Subcutaneous Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Subcutaneous Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Subcutaneous Injection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Subcutaneous Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Subcutaneous Injection market.
Global Subcutaneous Injection Scope and Market Size
Subcutaneous Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Subcutaneous Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Segment by Application
Hospital
Clinic
Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Roche
GSK
Endo International
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Injection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Subcutaneous Injection Equipment
1.2.3 Subcutaneous Injection Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Subcutaneous Injection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Injection Market Perspective (2016-2027)
2.2 Subcutaneous Injection Growth Trends by Regions
2.2.1 Subcutaneous Injection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Subcutaneous Injection Historic Market Share by Regions (2016-2021)
2.2.3 Subcutaneous Injection Forecasted Market Size by Regions (2022-2027)
2.3 Subcutaneous Injection Industry Dynamic
2.3.1 Subcutaneous Injection Market Trends
2.3.2 Subcutaneous Injection Market Drivers
2.3.3 Subcutaneous Injection Market Challenges
2.3.4 Subcutaneous Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Injection Players by Revenue
3.1.1 Global Top Subcutaneous Injection Players by Revenue (2016-2021)
3.1.2 Global Subcutaneous Injection Revenue Market Share by Players (2016-2021)
3.2 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Subcutaneous Injection Revenue
3.4 Global Subcutaneous Injection Market Concentration Ratio
3.4.1 Global Subcutaneous Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Injection Revenue in 2020
3.5 Subcutaneous Injection Key Players Head office and Area Served
3.6 Key Players Subcutaneous Injection Product Solution and Service
3.7 Date of Enter into Subcutaneous Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Injection Breakdown Data by Type
4.1 Global Subcutaneous Injection Historic Market Size by Type (2016-2021)
4.2 Global Subcutaneous Injection Forecasted Market Size by Type (2022-2027)
5 Subcutaneous Injection Breakdown Data by Application
5.1 Global Subcutaneous Injection Historic Market Size by Application (2016-2021)
5.2 Global Subcutaneous Injection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Subcutaneous Injection Market Size (2016-2027)
6.2 North America Subcutaneous Injection Market Size by Type
6.2.1 North America Subcutaneous Injection Market Size by Type (2016-2021)
6.2.2 North America Subcutaneous Injection Market Size by Type (2022-2027)
6.2.3 North America Subcutaneous Injection Market Size by Type (2016-2027)
6.3 North America Subcutaneous Injection Market Size by Application
6.3.1 North America Subcutaneous Injection Market Size by Application (2016-2021)
6.3.2 North America Subcutaneous Injection Market Size by Application (2022-2027)
6.3.3 North America Subcutaneous Injection Market Size by Application (2016-2027)
6.4 North America Subcutaneous Injection Market Size by Country
6.4.1 North America Subcutaneous Injection Market Size by Country (2016-2021)
6.4.2 North America Subcutaneous Injection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Subcutaneous Injection Market Size (2016-2027)
7.2 Europe Subcutaneous Injection Market Size by Type
7.2.1 Europe Subcutaneous Injection Market Size by Type (2016-2021)
7.2.2 Europe Subcutaneous Injection Market Size by Type (2022-2027)
7.2.3 Europe Subcutaneous Injection Market Size by Type (2016-2027)
7.3 Europe Subcutaneous Injection Market Size by Application
7.3.1 Europe Subcutaneous Injection Market Size by Application (2016-2021)
7.3.2 Europe Subcutaneous Injection Market Size by Application (2022-2027)
7.3.3 Europe Subcutaneous Injection Market Size by Application (2016-2027)
7.4 Europe Subcutaneous Injection Market Size by Country
7.4.1 Europe Subcutaneous Injection Market Size by Country (2016-2021)
7.4.2 Europe Subcutaneous Injection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Injection Market Size (2016-2027)
8.2 Asia-Pacific Subcutaneous Injection Market Size by Type
8.2.1 Asia-Pacific Subcutaneous Injection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Subcutaneous Injection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Subcutaneous Injection Market Size by Type (2016-2027)
8.3 Asia-Pacific Subcutaneous Injection Market Size by Application
8.3.1 Asia-Pacific Subcutaneous Injection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Subcutaneous Injection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Subcutaneous Injection Market Size by Application (2016-2027)
8.4 Asia-Pacific Subcutaneous Injection Market Size by Region
8.4.1 Asia-Pacific Subcutaneous Injection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Subcutaneous Injection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Subcutaneous Injection Market Size (2016-2027)
9.2 Latin America Subcutaneous Injection Market Size by Type
9.2.1 Latin America Subcutaneous Injection Market Size by Type (2016-2021)
9.2.2 Latin America Subcutaneous Injection Market Size by Type (2022-2027)
9.2.3 Latin America Subcutaneous Injection Market Size by Type (2016-2027)
9.3 Latin America Subcutaneous Injection Market Size by Application
9.3.1 Latin America Subcutaneous Injection Market Size by Application (2016-2021)
9.3.2 Latin America Subcutaneous Injection Market Size by Application (2022-2027)
9.3.3 Latin America Subcutaneous Injection Market Size by Application (2016-2027)
9.4 Latin America Subcutaneous Injection Market Size by Country
9.4.1 Latin America Subcutaneous Injection Market Size by Country (2016-2021)
9.4.2 Latin America Subcutaneous Injection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Injection Market Size (2016-2027)
10.2 Middle East & Africa Subcutaneous Injection Market Size by Type
10.2.1 Middle East & Africa Subcutaneous Injection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Subcutaneous Injection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Subcutaneous Injection Market Size by Type (2016-2027)
10.3 Middle East & Africa Subcutaneous Injection Market Size by Application
10.3.1 Middle East & Africa Subcutaneous Injection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Subcutaneous Injection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Subcutaneous Injection Market Size by Application (2016-2027)
10.4 Middle East & Africa Subcutaneous Injection Market Size by Country
10.4.1 Middle East & Africa Subcutaneous Injection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Subcutaneous Injection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Details
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Subcutaneous Injection Introduction
11.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2016-2021)
11.1.5 Becton Dickinson Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Details
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Subcutaneous Injection Introduction
11.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2016-2021)
11.2.5 Daiichi Sankyo Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Subcutaneous Injection Introduction
11.3.4 Sanofi Revenue in Subcutaneous Injection Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Subcutaneous Injection Introduction
11.4.4 Roche Revenue in Subcutaneous Injection Business (2016-2021)
11.4.5 Roche Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Subcutaneous Injection Introduction
11.5.4 GSK Revenue in Subcutaneous Injection Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Subcutaneous Injection Introduction
11.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Asahi Kasei Pharma
11.7.1 Asahi Kasei Pharma Company Details
11.7.2 Asahi Kasei Pharma Business Overview
11.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction
11.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2016-2021)
11.7.5 Asahi Kasei Pharma Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction
11.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2016-2021)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 Antares Pharma, Inc.
11.9.1 Antares Pharma, Inc. Company Details
11.9.2 Antares Pharma, Inc. Business Overview
11.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction
11.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2016-2021)
11.9.5 Antares Pharma, Inc. Recent Development
11.10 Eisai Co.，Ltd
11.10.1 Eisai Co.，Ltd Company Details
11.10.2 Eisai Co.，Ltd Business Overview
11.10.3 Eisai Co.，Ltd Subcutaneous Injection Introduction
11.10.4 Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2016-2021)
11.10.5 Eisai Co.，Ltd Recent Development
11.11 Chugai Pharmaceutical
11.11.1 Chugai Pharmaceutical Company Details
11.11.2 Chugai Pharmaceutical Business Overview
11.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction
11.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2016-2021)
11.11.5 Chugai Pharmaceutical Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Subcutaneous Injection Introduction
11.12.4 Endo International Revenue in Subcutaneous Injection Business (2016-2021)
11.12.5 Endo International Recent Development
11.13 PenJet Corporation
11.13.1 PenJet Corporation Company Details
11.13.2 PenJet Corporation Business Overview
11.13.3 PenJet Corporation Subcutaneous Injection Introduction
11.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2016-2021)
11.13.5 PenJet Corporation Recent Development
11.14 Aspen Medical Group
11.14.1 Aspen Medical Group Company Details
11.14.2 Aspen Medical Group Business Overview
11.14.3 Aspen Medical Group Subcutaneous Injection Introduction
11.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2016-2021)
11.14.5 Aspen Medical Group Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Subcutaneous Injection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Subcutaneous Injection Equipment
Table 3. Key Players of Subcutaneous Injection Drug
Table 4. Key Players of Others
Table 5. Global Subcutaneous Injection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Subcutaneous Injection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Subcutaneous Injection Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Subcutaneous Injection Market Share by Regions (2016-2021)
Table 9. Global Subcutaneous Injection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Subcutaneous Injection Market Share by Regions (2022-2027)
Table 11. Subcutaneous Injection Market Trends
Table 12. Subcutaneous Injection Market Drivers
Table 13. Subcutaneous Injection Market Challenges
Table 14. Subcutaneous Injection Market Restraints
Table 15. Global Subcutaneous Injection Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Subcutaneous Injection Market Share by Players (2016-2021)
Table 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injection as of 2020)
Table 18. Ranking of Global Top Subcutaneous Injection Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Subcutaneous Injection Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Subcutaneous Injection Product Solution and Service
Table 22. Date of Enter into Subcutaneous Injection Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Subcutaneous Injection Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Subcutaneous Injection Revenue Market Share by Type (2016-2021)
Table 26. Global Subcutaneous Injection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Subcutaneous Injection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Subcutaneous Injection Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Subcutaneous Injection Revenue Market Share by Application (2016-2021)
Table 30. Global Subcutaneous Injection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Subcutaneous Injection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Subcutaneous Injection Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Subcutaneous Injection Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Subcutaneous Injection Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Subcutaneous Injection Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Subcutaneous Injection Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Subcutaneous Injection Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Subcutaneous Injection Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Subcutaneous Injection Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Subcutaneous Injection Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Subcutaneous Injection Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Subcutaneous Injection Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Subcutaneous Injection Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Subcutaneous Injection Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Subcutaneous Injection Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Subcutaneous Injection Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Subcutaneous Injection Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Subcutaneous Injection Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Subcutaneous Injection Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Subcutaneous Injection Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Subcutaneous Injection Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Subcutaneous Injection Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Subcutaneous Injection Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Subcutaneous Injection Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Subcutaneous Injection Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Subcutaneous Injection Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Subcutaneous Injection Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Subcutaneous Injection Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Subcutaneous Injection Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Subcutaneous Injection Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Subcutaneous Injection Market Size by Country (2022-2027) & (US$ Million)
Table 62. Becton Dickinson Company Details
Table 63. Becton Dickinson Business Overview
Table 64. Becton Dickinson Subcutaneous Injection Product
Table 65. Becton Dickinson Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 66. Becton Dickinson Recent Development
Table 67. Daiichi Sankyo Company Details
Table 68. Daiichi Sankyo Business Overview
Table 69. Daiichi Sankyo Subcutaneous Injection Product
Table 70. Daiichi Sankyo Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 71. Daiichi Sankyo Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Subcutaneous Injection Product
Table 75. Sanofi Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Subcutaneous Injection Product
Table 80. Roche Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 81. Roche Recent Development
Table 82. GSK Company Details
Table 83. GSK Business Overview
Table 84. GSK Subcutaneous Injection Product
Table 85. GSK Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 86. GSK Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Subcutaneous Injection Product
Table 90. Eli Lilly Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Asahi Kasei Pharma Company Details
Table 93. Asahi Kasei Pharma Business Overview
Table 94. Asahi Kasei Pharma Subcutaneous Injection Product
Table 95. Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 96. Asahi Kasei Pharma Recent Development
Table 97. Takeda Pharmaceutical Company Details
Table 98. Takeda Pharmaceutical Business Overview
Table 99. Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 100. Takeda Pharmaceutical Recent Development
Table 101. Antares Pharma, Inc. Company Details
Table 102. Antares Pharma, Inc. Business Overview
Table 103. Antares Pharma, Inc. Subcutaneous Injection Product
Table 104. Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 105. Antares Pharma, Inc. Recent Development
Table 106. Eisai Co.，Ltd Company Details
Table 107. Eisai Co.，Ltd Business Overview
Table 108. Eisai Co.，Ltd Subcutaneous Injection Product
Table 109. Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 110. Eisai Co.，Ltd Recent Development
Table 111. Chugai Pharmaceutical Company Details
Table 112. Chugai Pharmaceutical Business Overview
Table 113. Chugai Pharmaceutical Subcutaneous Injection Product
Table 114. Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 115. Chugai Pharmaceutical Recent Development
Table 116. Endo International Company Details
Table 117. Endo International Business Overview
Table 118. Endo International Subcutaneous Injection Product
Table 119. Endo International Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 120. Endo International Recent Development
Table 121. PenJet Corporation Company Details
Table 122. PenJet Corporation Business Overview
Table 123. PenJet Corporation Subcutaneous Injection Product
Table 124. PenJet Corporation Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 125. PenJet Corporation Recent Development
Table 126. Aspen Medical Group Company Details
Table 127. Aspen Medical Group Business Overview
Table 128. Aspen Medical Group Subcutaneous Injection Product
Table 129. Aspen Medical Group Revenue in Subcutaneous Injection Business (2016-2021) & (US$ Million)
Table 130. Aspen Medical Group Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Subcutaneous Injection Market Share by Type: 2020 VS 2027
Figure 2. Subcutaneous Injection Equipment Features
Figure 3. Subcutaneous Injection Drug Features
Figure 4. Others Features
Figure 5. Global Subcutaneous Injection Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Laboratory Case Studies
Figure 9. Others Case Studies
Figure 10. Subcutaneous Injection Report Years Considered
Figure 11. Global Subcutaneous Injection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Subcutaneous Injection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Subcutaneous Injection Market Share by Regions: 2020 VS 2027
Figure 14. Global Subcutaneous Injection Market Share by Regions (2022-2027)
Figure 15. Global Subcutaneous Injection Market Share by Players in 2020
Figure 16. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Injection as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Subcutaneous Injection Revenue in 2020
Figure 18. Global Subcutaneous Injection Revenue Market Share by Type (2016-2021)
Figure 19. Global Subcutaneous Injection Revenue Market Share by Type (2022-2027)
Figure 20. North America Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Subcutaneous Injection Market Share by Type (2016-2027)
Figure 22. North America Subcutaneous Injection Market Share by Application (2016-2027)
Figure 23. North America Subcutaneous Injection Market Share by Country (2016-2027)
Figure 24. United States Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Subcutaneous Injection Market Share by Type (2016-2027)
Figure 28. Europe Subcutaneous Injection Market Share by Application (2016-2027)
Figure 29. Europe Subcutaneous Injection Market Share by Country (2016-2027)
Figure 30. Germany Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Subcutaneous Injection Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Subcutaneous Injection Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Subcutaneous Injection Market Share by Region (2016-2027)
Figure 40. China Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Subcutaneous Injection Market Share by Type (2016-2027)
Figure 48. Latin America Subcutaneous Injection Market Share by Application (2016-2027)
Figure 49. Latin America Subcutaneous Injection Market Share by Country (2016-2027)
Figure 50. Mexico Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Subcutaneous Injection Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Subcutaneous Injection Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Subcutaneous Injection Market Share by Country (2016-2027)
Figure 56. Turkey Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Subcutaneous Injection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Becton Dickinson Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 65. Asahi Kasei Pharma Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 66. Takeda Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 67. Antares Pharma, Inc. Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 68. Eisai Co.，Ltd Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 69. Chugai Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 70. Endo International Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 71. PenJet Corporation Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 72. Aspen Medical Group Revenue Growth Rate in Subcutaneous Injection Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の皮下注射市場規模・現状・予測（2021年-2027年） A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …- 世界の皮下注射市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の皮下生物製剤市場規模・現状・予測（2021年-2027年） Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances. M…
- 世界の皮下生物製剤市場規模・現状・予測（2021年-2027年） Biologics are all the pharmaceutical products developed using a biological process. Biologic products include drug manufactured from the various living organism with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein or their combination of these substances. M…
- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …